Method of treating a pathological syndrome and a pharmaceutical agent
Abstract
A method of treating a pathological syndrome includes administration of an activated form of ultra-low doses of antibodies to an antigen, wherein said activated form is obtained by repeated consecutive dilution combined with external impact, and the antigen is a substance or a pharmaceutical agent exerting influence upon the mechanisms of formation of this particular pathological syndrome. Pharmaceutical agent for treating a pathological syndrome contains activated form of ultra-low doses of monoclonal, polyclonal or natural antibodies to an antigen, wherein said activated form is prepared by means of repeated consecutive dilution and external treatment, predominantly based on homeopathic technology, and said antigen is a substance or a drug acting as a direct cause of the pathological syndrome or involved in regulation of mechanisms of its formation. At that, activated forms of ultra-low doses of antibodies are raised against antigens of exogenous or endogenous origin, against autologous antigens, fetal antigens; anti-idiotypic antibodies are used too.
Claims
exact text as granted — not AI-modified1 - 16 . (canceled)
17 . A method of treating a disease or condition in a human, said disease or condition regulated by an endogenous biological molecule, said method comprising administering to said human a homeopathically potentized form of an antibody to said endogenous biological molecule.
18 . The method of claim 17 , wherein said endogenous biological molecule is angiotensin-converting enzyme.
19 . The method of claim 17 , wherein said endogenous biological molecule is angiotensin II.
20 .- 33 . (canceled)Join the waitlist — get patent alerts
Track US2016176987A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.